Insights & Thoughts – May 12, 2022 BLOG: Satellite images, Artificial Intelligence and our investment into Geospatial Intelligence Software, Picterra Read More
Portfolio – Apr 26, 2022 Picterra raises $6.5M to accelerate its mission of democratizing geospatial mapping Read More
Insights & Thoughts – Apr 21, 2022 BLOG: The new “remote” world and our investment into Unique Read More
Portfolio – Apr 05, 2022 Sequana Medical announces the completion of alfapump implantations in POSEIDON, the North American pivotal alfapump study Read More
Portfolio – Mar 30, 2022 Altoida upsizes its Series A Round to $20.3M to Advance Its First in Class AI-Powered Neurocognitive Assessment Platform Read More
Firm – Mar 08, 2022 VI Partners strengthens team with Olivier Laplace as new Partner for Technology Investments Read More
Portfolio – Mar 02, 2022 Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics Read More
Portfolio – Feb 24, 2022 Altoida Announces Partnership with Click Therapeutics to Power Clinical Trials with Digital Cognitive Assessment Read More
Portfolio – Feb 07, 2022 Altoida Partners With GN Group to Research and Develop New Cognitive Assessment Technology to Detect Mild Cognitive Impairment Read More
Portfolio – Jan 18, 2022 JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited Read More
Portfolio – Jan 05, 2022 Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China) Read More
Portfolio – Jan 03, 2022 HighLife’s TSMVR Technology successfully used for the first time in China Read More
Portfolio – Dec 09, 2021 Altoida Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups Read More
Portfolio – Dec 07, 2021 Sequana Medical announces positive interim results of SAHARA DESERT trial Read More
Portfolio – Nov 22, 2021 Inositec acquired by Vifor Pharma for its program in first-in-class treatment for progressive vascular calcification Read More
Portfolio – Nov 12, 2021 Oculis announces patient dosing in its diamond study DIAMOND, its first phase 3 study with OCS-01 Read More
Portfolio – Nov 11, 2021 Araris Biotech AG Expands Scientific Advisory Board with Appointment of Dr. Jeff Sharman and Dr. Clive Stanway Read More
Firm – Nov 05, 2021 Susan M. Gasser, advisor to VI Partners, receives honorary doctorate by University of Fribourg Read More
Portfolio – Oct 25, 2021 Altoida and Ionian University Investigate Breakthrough Software Device for Parkinson’s Disease Diagnosis Read More
Portfolio – Oct 18, 2021 Altoida Launches 5-Year Multi-Center Alzheimer’s Study with Eisai and Ionian University Read More
Portfolio – Oct 13, 2021 Acodis accelerates its growth with a CHF 2.5m financing led by VI Partners Read More
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)